We describe the case of a 59-year-old woman who presented with progressive bilateral vestibular hypofunction and who was found to have bilateral granulomatous mass lesions of the mesial temporal lobe. Initially, her condition stabilized neurologically with corticosteroids, but a diagnosis of neurosarcoidosis was delayed because of the unusual presentation and persistently normal chest imaging results and serum angiotensin-converting enzyme (ACE) levels.
Introduction
Sarcoidosis is a chronic multisystem granulomatous disorder of unclear etiology. Pathologically, it features diseased tissue that is characterized by the presence of epithelioid, noncaseating granulomas. Neurosarcoidosis is a rare manifestation of this disease, clinically affecting only 5% of all patients with sarcoidosis. 1 The most common neurologic feature of neurosarcoidosis is cranial neuropathy, which is attributable to frequent granulomatous involvement of the basal leptomeninges. Parenchymatous disease may also occur, most often in the hypothalamus and the pituitary gland. 2 Audiovestibular dysfunction in neurosarcoidosis is rare. In an extensive review of neurosarcoidosis case reports, Colvin found that 28 of 31 patients (90%) for whom audiometric data were available had experienced either a sudden or rapidly progressive hearing loss. 3 Among 24 patients who had undergone vestibular function testing, 23 had abnormal results; of these 23, 6 had unilateral and 16 had bilateral loss of vestibular function (the remaining patient's study was nonlocalizing). Vestibular impairment in the absence of hearing loss may also occur. 4 In this article, we describe an unusual case of neurosarcoidosis that featured the rare manifestation of bilateral vestibular dysfunction in the absence of auditory impairment.
Case report
A 59-year-old woman presented with a 4-month history of progressive gait imbalance without vertigo. Examination showed a widened gait base and poor balance. Hearing, speech, articulation, and vision were normal. Magnetic resonance imaging (MRI) of the brain demonstrated an increased signal on gadolinium-enhanced T1-weighted imaging in the mesial right temporal lobe and minimal change in the left temporal lobe (fi gure 1, A). A diagnosis of herpes simplex encephalitis was entertained along with other infectious, infl ammatory, and neoplastic etiologies. Cerebrospinal fl uid (CSF) studies revealed 14 white blood cells/µl, which were 100% lymphocytes; a CSF glucose level of 57 mg/dl; and a CSF protein concentration of 52 mg/dl. Bacterial and fungal cultures were negative, as was a polymerase chain reaction assay for herpes simplex in CSF. In addition, fi ndings on CSF VDRL testing, coccidioides serology, cerebral angiography, and chest x-ray were all normal. Electroencephalography (EEG) showed bitemporal slowing, but no epileptiform changes. The serum angiotensin-converting enzyme (ACE) level (17 U/L) and serum calcium concentration (9.7 mg/dl) were both within normal limits. A purifi ed protein derivative of a tuberculin skin test was negative, but the patient was anergic to mumps. An excisional biopsy of the right temporal lobe revealed lymphoplasmacytic infl ammation with noncaseating granulomas, clusters of fi broblasts and histiocytes, and multinucleated giant cells (fi gure 2). No cultures grew from the specimen. Antimicrobial therapy was given empirically; it included ceftriaxone, acyclovir, isoniazid, rifampin, ethambutol, and pyrazinamide. The patient was also started on dexamethasone at 8 mg twice daily.
At a follow-up appointment 2 months later, the patient had shown some improvement in her balance, and a repeat MRI demonstrated a partial resolution of the right temporal lesion. The decision was made to taper the steroids and continue the antimicrobial therapy. However, 2 weeks later (and 7 months after her initial onset of imbalance), the patient returned with complaints of acute amnesia and confusion. She said she woke up feeling that she had "lost one and a half years" of memory. On examination, her attention and registration were good, but her recall was poor. She was completely unaware of the events that had led to her current health situation. She exhibited delusional thinking at times. Prior to her current situation, she had no history of behavioral change or cognitive defi cit. Her dizziness had also progressed to the point where she felt unable to sit up. A repeat MRI demonstrated signifi cant progression of the left temporal lesion and a slight enlargement of the area of signal change in the hippocampal area on the right side (fi gure 1, B). Repeat EEG monitoring revealed generalized slowing and no seizures, but phenytoin was started empirically. Computed tomography (CT) scans of the chest, abdomen, and pelvis were negative. A gallium scan demonstrated focal uptake in the hila of both lungs consistent with sarcoidosis, which had not been evident on chest x-ray and chest CT. The patient was stabilized neurologically with methylprednisolone at 1,000 mg/day for 5 days. She was discharged on prednisone at 60 mg/day.
On outpatient follow-up, rotational and caloric vestibular testing demonstrated severe bilateral loss of peripheral vestibular function. The patient's hearing remained intact, and no uveitis or periocular sarcoidosis was observed. Five months later, she died from complications of a myocardial infarction and pulmonary embolism.
Discussion
In this case, the initial complaint was of imbalance, which was most likely caused by the progressive bilateral vestibular dysfunction. Bilateral vestibular hypofunction may present without nystagmus, nausea, or vertigo, particularly if the loss of function occurs symmetrically or gradually. Sakakibara et al reported a case of vestibular dysfunction that produced progressive ataxia, but that case also featured some element of communicating hydrocephalus that might have contributed to the ataxia. 5 Loss of vestibular function has been reported both with 5-10 and without 4 hearing loss. Hearing loss secondary to sarcoidosis is often bilateral and frequently associated with fl uctuating hearing. In an extensive review of the literature, Mende and Suchenwirth found hearing loss in 12.2% of patients with neurosarcoidosis and nystagmus in 8.6%. 11 On the other hand, Hybels and Rice found audiovestibular dysfunction to be more common. 12 Colvin's review of 48 case reports and 2 additional cases found normal hearing in only 1 of 22 patients for whom pure-tone audiometric data were available, suggesting that vestibular loss with spared hearing is quite rare among patients with neurosarcoidosis. 3 Sarcoidosis-related vestibular dysfunction may occur as a result of vasculitis or granulomatous infl ammation of the vestibulocochlear nerves 4,7 and perhaps by direct labyrinthine involvement. 13 Auditory impairment may be caused by granulomatous infl ammation of the arachnoid vessels, the cochlear nuclei, vestibulocochlear nerves, or the labyrinth itself. 10 Von Brevern et al found 14 The authors hypothesized that sarcoidosis in this area begins as a reversible neuropathy and evolves over time to an irreversible degeneration of neuroepithelium and nerve elements. In our patient, vestibular function never returned, although it is possible that corticosteroids had been administered too late in the clinical course to induce a recovery. Parenchymal mass lesions have been seen in neurosarcoidosis, and they may mimic gliomas or lymphoma. 15 Our patient developed both an anterograde and temporally graded retrograde amnesia that was clinically and radiographically consistent with the syndrome of bitemporal amnesia. 16 A normal chest x-ray, chest CT, and serum ACE level do not exclude the possibility of neurosarcoidosis. 17, 18 A tissue biopsy may be the only means of making the diagnosis in such instances. 19 A gallium scan 20 or whole-body positron-emission tomography 17,21 may also help with the diagnosis if changes are seen in the pulmonary hila or salivary glands, and such imaging may direct the location for a biopsy. Corticosteroids may be used empirically but with caution, and every attempt should be made to confi rm a diagnosis because some neurologic manifestations of sarcoidosis may fail to improve with steroids and require more aggressive immunomodulating drugs. 22 
Figure 2. A: The histologic section from the right temporal lobe biopsy demonstrates non-necrotizing granulomatous infl ammation consisting of nodular foci of numerous histiocytes, lymphocytes, and plasma cells. A multinucleated giant cell (MNGC) is also seen (DAB and hematoxylin, original magnifi cation ×100). B: At higher power, a noncaseating granuloma (arrows) demonstrates mononuclear histiocytes admixed with an MNGC (DAB and hematoxylin, original magnifi cation ×400).
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